Inventor · disambiguated record
Tao Liu
Also filed as: LIU TAO · Liu tao yan
58 granted patents·44 pending applications·318 citations·filing 2004–2025
98Inventor score
Files withINFINITY PHARMACEUTICALS INC28AGIOS PHARMACEUTICALS INC9CHINA PETROLEUM & CHEM CORP8UNIV ZHEJIANG6CASTRO ALFREDO C5
Top patents by PatentIndex Score
102 records- 0197US11040036B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Jun 22, 2021·7 cites·26 claims
- 0297US8785470B2Heterocyclic compounds and uses thereofCASTRO ALFREDO C·Filed 2012·Granted Jul 22, 2014·41 cites·24 claims
- 0396US9359365B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jun 7, 2016·24 cites·24 claims
- 0496US8969363B2Heterocyclic compounds and uses thereofCASTRO ALFREDO C·Filed 2012·Granted Mar 3, 2015·44 cites·56 claims
- 0596US8940742B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Jan 27, 2015·35 cites·48 claims
- 0695US9115141B2Substituted isoquinolinones and methods of treatment thereofINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Aug 25, 2015·27 cites·49 claims
- 0794US9775844B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Oct 3, 2017·13 cites·48 claims
- 0894US9255108B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Feb 9, 2016·21 cites·45 claims
- 0993US9056877B2Heterocyclic compounds and uses thereofCASTRO ALFREDO C·Filed 2012·Granted Jun 16, 2015·25 cites·32 claims
- 1092US10329299B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Jun 25, 2019·7 cites·26 claims
- 1191US11541059B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2020·Granted Jan 3, 2023·2 cites·11 claims
- 1289US11464775B2Pyruvate kinase modulators and use thereofAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 11, 2022·3 cites·21 claims
- 1389US2025144093A1Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1488US11364240B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Jun 21, 2022·4 cites·27 claims
- 1587US9828377B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·4 cites·43 claims
- 1687US7947663B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2007·Granted May 24, 2011·6 cites·12 claims
- 1785US9068030B2Propylene homopolymer having high melt strength and preparation method thereofSONG WENBO·Filed 2011·Granted Jun 30, 2015·16 cites·19 claims
- 1885US7851637B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY PHARMACEUTICALS INC·Filed 2005·Granted Dec 14, 2010·13 cites·17 claims
- 1984US12133853B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Nov 5, 2024·0 cites·25 claims
- 2083US12497622B2Nucleic acid, pharmaceutical composition, conjugate, preparation method, and useSUZHOU RIBO LIFE SCIENCE CO LTD·Filed 2020·Granted Dec 16, 2025·1 cites·26 claims
- 2182US10822327B22-substituted aromatic ring-pyrimidine derivative and preparation and application thereofUNIV ZHEJIANG·Filed 2017·Granted Nov 3, 2020·4 cites·9 claims
- 2282US8349814B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2011·Granted Jan 8, 2013·3 cites·17 claims
- 2382US2025171453A1Heterocyclic compounds and uses thereofTWELVE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2481US11957680B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2022·Granted Apr 16, 2024·0 cites·14 claims
- 2581US10442793B2Oxa spiro derivative, preparation method therefor, and applications thereof in medicinesJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Oct 15, 2019·2 cites·24 claims
- 2681US9605003B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Mar 28, 2017·3 cites·39 claims
- 2781US8629125B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2012·Granted Jan 14, 2014·3 cites·18 claims
- 2879US11872225B2Pyruvate kinase modulators and use thereofAGIOS PHARMACEUTICALS INC·Filed 2022·Granted Jan 16, 2024·0 cites·22 claims
- 2979US11590132B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Feb 28, 2023·1 cites·24 claims
- 3079US9751888B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Sep 5, 2017·2 cites·19 claims
- 3178US2024050437A1Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3277US9546180B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Jan 17, 2017·2 cites·29 claims
- 3377US8329675B2Inhibitors of fatty acid amide hydrolaseADAMS JULIAN·Filed 2011·Granted Dec 11, 2012·2 cites·31 claims
- 3476US12152032B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2021·Granted Nov 26, 2024·0 cites·17 claims
- 3575US9108989B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Aug 18, 2015·1 cites·16 claims
- 3668US8765735B2Isoxazolines as inhibitors of fatty acid amide hydrolaseBEHNKE MARK L·Filed 2010·Granted Jul 1, 2014·1 cites·30 claims
- 3768US2019367521A1Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3867US12351591B2KRas inhibitorsLILLY CO ELI·Filed 2023·Granted Jul 8, 2025·0 cites·33 claims
- 3967US12319773B2Carrier for olefin polymerization catalyst, and preparation method therefor and application thereofCHINA PETROLEUM & CHEM CORP·Filed 2019·Granted Jun 3, 2025·0 cites·23 claims
- 4066US2024343852A1Resin composition and application thereofHUAWEI TECH CO LTD·Filed 2024·Application pending·0 cites
- 4165US2025171910A1Seawater non-desalination in-situ direct electrolysis hydrogen production method, apparatus, and systemUNIV SHENZHEN·Filed 2022·Application pending·0 cites
- 4264US12180175B2Water-soluble ynamide coupling reagent and preparation method and use thereofXIAN EASY PEPTIDE BIOTECHNOLOGY CO LTD·Filed 2021·Granted Dec 31, 2024·0 cites·9 claims
- 4364US2025320318A1Olefin polymerization catalyst component, catalyst system, prepolymerization catalyst composition and olefin polymerization methodCHINA PETROLEUM & CHEM CORP·Filed 2022·Application pending·0 cites
- 4464US2022346375A1Idl6 mature polypeptide plant aging promoter, and preparation method and application thereofTOBACCO RES INST CAAS·Filed 2022·Application pending·0 cites
- 4563US10233180B2Substituted nitrogen-containing heterocyclic derivatives, pharmaceutical compositions comprising the same and applications of antitumor thereofUNIV ZHEJIANG·Filed 2015·Granted Mar 19, 2019·1 cites·4 claims
- 4663US2025236753A1Polypropylene microsphere and preparation method therefor, 3d printing raw material, and useCHINA PETROLEUM & CHEM CORP·Filed 2022·Application pending·0 cites
- 4763US2024316541A1Metal modified zsm-5 molecular sieve catalyst, preparation method and application thereofPETROCHINA CO LTD·Filed 2024·Application pending·0 cites
- 4863US2025289830A1Kras inhibitorsLILLY CO ELI·Filed 2025·Application pending·0 cites
- 4961US2022400672A1Idl7 mature polypeptide plant senescence accelerator, preparation method and application thereofTOBACCO RES INST CAAS·Filed 2021·Application pending·0 cites
- 5061US2024392235A1Pseudomonas and use thereofCHINA PETROLEUM & CHEM CORP·Filed 2022·Application pending·0 cites
Showing the top 50 of 102 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Tao Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →